甲型H1N1流感预后的预判因子研究进展(4)
[3]Rodrigo C,Leonardi-Bee J,Nguyen-Van-Tam J,et al.Corticosteroids as adjunctive therapy in the treatment of influenza[J].Cochrane Database Syst Rev,2016,7(3)C:D010406.
[4]中华人民共和国国家卫生和计划生育委员会.流行性感冒诊疗方案(2018年版)[J].中华临床感染病杂志,2018,11(1):1-5.
[5]Radigan KA,Morales-Nebreda L,Soberanes S,et al.Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages[J].PLoS One,2014,9(9):e108138.
, http://www.100md.com
[6]Hlavinkova L,Kristufkova Z,Mikas J.Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09[J].Bratisl Lek Listy,2015,116(6):389-393.
[7]Littauer EQ,Esser ES,Antao OQ,et al.H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation[J].PLoS Pathog,2017,13(11):e1006757.
[8]Periolo N,Avaro M,Czech A,et al.Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity[J].J Clin Virol,2015,64(1):52-58.
, 百拇医药
[9]Sun Y,Wang Q,Yang G,et al.Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis[J].Infect Dis (Lond),2016,48(11-12):813-822.
[10]肖卫强,周国俊,许成云,等.不同模式口鼻式吸烟诱导急性肺损伤的实验研究[J].浙江大学学报(医学版),2016,45(5):522-529.
[11]刘童,安利国,杨桂文.TRIM在病毒免疫防御机制中的作用[J].国际病毒学杂志,2012,19(2):57-60.
[12]王宗义,胡爱荣,蒋素文,等.轻症和重症甲型H1N1流感患者免疫学特征比较分析[J].中华微生物学和免疫学杂志,2013,33(9):673-676.
, 百拇医药
[13]钱永兵,谢晖,田锐.早期免疫功能麻痹在重症甲型H1N1流感中的临床意义[J].中华危重病急救医学,2017,29(7):581-585.
[14]董旭南,张南,徐佩茹,等.新疆甲型H1N1流感重症病例的临床特征分析[J].中国中西医结合急救杂志,2011,18(1):25-27.
[15]张立成,张锦前,郭利民,等.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特点及危险因素分析[J].中华实验和临床感染病杂志,2014,8(3):22-27.
[16]张梓童.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特征[J].实用临床医药杂志,2016,20(11):172-174.
[17]Bouneb R,Mellouli M,Bensoltane H,et al.Characteristics and outcome of ill Critical patients with influenza A infection[J].Pan Afr Med J,2018(29):174.
, 百拇医药
[18]李燕明,居阳,佟训靓,等.老年重症甲型H1N1流感的临床特征分析[J].国际呼吸杂志,2015,35(12):899-903.
[19]Vasileva D,Badawi A.C-reactive protein as a biomarker of severe H1N1 influenza[J].Inflamm Res,2018,68(1):39-46.
[20]張学军,张庆,邢志俐,等.重症及危重症甲型H1N1流感患者血气分析及电解质水平变化研究[J].中国全科医学,2013,6(9):2959-2961.
[21]廖海军,张中伟.全身炎症反应综合征患者血磷变化及其意义[J].航空航天医药,2006,17(1):48-49.
[22]刘会,刘桐希,谢晟,等.重症与危重症甲型H1N1流感肺炎的影像学特点比较分析以及临床联系[J].实用放射学杂志,2017,33(1):47-50., 百拇医药(袁金壑)
[4]中华人民共和国国家卫生和计划生育委员会.流行性感冒诊疗方案(2018年版)[J].中华临床感染病杂志,2018,11(1):1-5.
[5]Radigan KA,Morales-Nebreda L,Soberanes S,et al.Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages[J].PLoS One,2014,9(9):e108138.
, http://www.100md.com
[6]Hlavinkova L,Kristufkova Z,Mikas J.Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09[J].Bratisl Lek Listy,2015,116(6):389-393.
[7]Littauer EQ,Esser ES,Antao OQ,et al.H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation[J].PLoS Pathog,2017,13(11):e1006757.
[8]Periolo N,Avaro M,Czech A,et al.Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity[J].J Clin Virol,2015,64(1):52-58.
, 百拇医药
[9]Sun Y,Wang Q,Yang G,et al.Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis[J].Infect Dis (Lond),2016,48(11-12):813-822.
[10]肖卫强,周国俊,许成云,等.不同模式口鼻式吸烟诱导急性肺损伤的实验研究[J].浙江大学学报(医学版),2016,45(5):522-529.
[11]刘童,安利国,杨桂文.TRIM在病毒免疫防御机制中的作用[J].国际病毒学杂志,2012,19(2):57-60.
[12]王宗义,胡爱荣,蒋素文,等.轻症和重症甲型H1N1流感患者免疫学特征比较分析[J].中华微生物学和免疫学杂志,2013,33(9):673-676.
, 百拇医药
[13]钱永兵,谢晖,田锐.早期免疫功能麻痹在重症甲型H1N1流感中的临床意义[J].中华危重病急救医学,2017,29(7):581-585.
[14]董旭南,张南,徐佩茹,等.新疆甲型H1N1流感重症病例的临床特征分析[J].中国中西医结合急救杂志,2011,18(1):25-27.
[15]张立成,张锦前,郭利民,等.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特点及危险因素分析[J].中华实验和临床感染病杂志,2014,8(3):22-27.
[16]张梓童.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特征[J].实用临床医药杂志,2016,20(11):172-174.
[17]Bouneb R,Mellouli M,Bensoltane H,et al.Characteristics and outcome of ill Critical patients with influenza A infection[J].Pan Afr Med J,2018(29):174.
, 百拇医药
[18]李燕明,居阳,佟训靓,等.老年重症甲型H1N1流感的临床特征分析[J].国际呼吸杂志,2015,35(12):899-903.
[19]Vasileva D,Badawi A.C-reactive protein as a biomarker of severe H1N1 influenza[J].Inflamm Res,2018,68(1):39-46.
[20]張学军,张庆,邢志俐,等.重症及危重症甲型H1N1流感患者血气分析及电解质水平变化研究[J].中国全科医学,2013,6(9):2959-2961.
[21]廖海军,张中伟.全身炎症反应综合征患者血磷变化及其意义[J].航空航天医药,2006,17(1):48-49.
[22]刘会,刘桐希,谢晟,等.重症与危重症甲型H1N1流感肺炎的影像学特点比较分析以及临床联系[J].实用放射学杂志,2017,33(1):47-50., 百拇医药(袁金壑)